*The following content is generated by AI and is for reference only.
Cefradine for Injection is a parenteral form of the first-generation cephalosporin antibiotic, primarily utilized for the treatment of moderate to severe bacterial infections when oral administration is not feasible or effective. This sterile powder must be reconstituted with an appropriate diluent, such as sterile water for injection or 0.9% sodium chloride, prior to intramuscular or slow intravenous administration. Its clinical scope covers respiratory tract infections, including pneumonia and bronchitis; urinary tract infections caused by susceptible organisms like *E. coli* and *Klebsiella*; skin and soft tissue infections; and bone infections such as osteomyelitis. The drug functions by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.
Key considerations for safe usage are paramount. First, Cefradine is contraindicated in patients with a known hypersensitivity to cephalosporins or penicillins due to the risk of cross-reactivity, which can manifest as mild rashes to life-threatening anaphylaxis. Healthcare providers must obtain a thorough allergy history before initiating therapy. Dosage adjustments are frequently required for patients with impaired renal function, as the drug is excreted unchanged by the kidneys; failure to adjust may lead to toxic accumulation. Common adverse effects include gastrointestinal disturbances, nausea, diarrhea, and local reactions at the injection site, such as pain or induration. Less frequently, patients may experience transient elevations in liver enzymes or hematological changes like eosinophilia.
Special caution is advised regarding prolonged use, which may result in superinfections caused by non-susceptible organisms, including *Clostridioides difficile*. It is essential to monitor patients closely for signs of pseudomembranous colitis during and after treatment. Furthermore, while generally safe, the use of Cefradine during pregnancy or lactation should only occur if clearly needed, balancing potential benefits against unknown risks to the fetus or nursing infant. Strict adherence to aseptic techniques during preparation and administration is critical to prevent iatrogenic contamination. Clinicians must ensure that culture and susceptibility tests are performed whenever possible to guide appropriate antimicrobial selection and minimize the development of resistance.